1 – 10 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study
(
- Contribution to journal › Article
- 2022
-
Mark
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors
(
- Contribution to journal › Article
-
Mark
Branching copy number evolution and parallel immune profiles across the regional tumor space of resected pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis
(
- Contribution to journal › Article
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations
(
- Contribution to journal › Article
-
Mark
Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumours
(
- Contribution to journal › Article
-
Mark
Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
(
- Contribution to journal › Article
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
(
- Contribution to journal › Article